Matrix metalloproteinases and their tissue inhibitors - expression, role and regulation in human malignant non-Hodgkin's lymphomas (Q34244468)

31 July 2017

1 reference

title

Matrix metalloproteinases and their tissue inhibitors - expression, role and regulation in human malignant non-Hodgkin's lymphomas (English)

1 reference

31 July 2017

Kossakowska AE

1

1 reference

PubMed ID

11342332

31 July 2017

Urbanski SJ

series ordinal

2

1 reference

PubMed ID

11342332

31 July 2017

Janowska-Wieczorek A

series ordinal

3

1 reference

31 July 2017

1 November 2000

1 reference

31 July 2017

1 reference

31 July 2017

39

1 reference

31 July 2017

485-493

1 reference

31 July 2017

5-6

1 reference

The extracellular matrix in large-cell lymphomas: a histopathologic, immunohistochemical, and ultrastructural study

31 July 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Steps in tumor metastasis: new concepts from intravital videomicroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

The matrix-degrading metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Expression of the active form of MMP-2 on the surface of leukemic cells accounts for their in vitro invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Expression of matrix metalloproteinases by human plasma cells and B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Type IV collagenases in tumor invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Induction of metalloproteinase activity in human T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Tissue inhibitors of metalloproteinases: evolution, structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Tissue inhibitors of matrix metalloproteinases in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Insights into MMP-TIMP interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

TIMP-2 growth-stimulatory activity: a concentration- and cell type-specific response in the presence of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

The roles of adhesion molecules and proteinases in lymphocyte transendothelial migration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Tumor necrosis factor alpha (TNFalpha) induces pro-matrix metalloproteinase 9 production in human uterine cervical fibroblasts but interleukin 1alpha antagonizes the inductive effect of TNFalpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

Interleukin-10 in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190009113379

10.3109/10428190009113379

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11342332